|
12.40 – 13.10
Hosted by Innovation Session
|
Macrophage Activation Syndrome in Rheumatic Diseases To give an introduction to the severely, potentially life-threatening disease, Macrophage Activation Syndrome that can arise as a complication of several chronic rheumatic diseases. This session will aim to aid diagnosis of MAS.
Professor Athimalaipet Ramanan, Consultant Paediatric Rheumatologist, Bristol Royal Hospital For Children & Royal National Hospital For Rheumatic Diseases, Bath
|
|
15.05 – 15.35
Hosted by
Innovation Session
|
From Pathogenesis to Precision Medicine This session will focus on the multiple immunological and intracellular pathways involved in the pathogenesis of Rheumatoid Arthritis. Different synovial pathology implicate distinct biological pathways, which leads to inflammation. Tailoring treatment to the underlying pathophysiology can aid development and optimal utilization of therapies and thus result in better management of this complex heterogeneous disease. The talk will be followed by a brief question and answer session.
Chair: Professor Peter Taylor, Norman Collisson, Professor of Musculoskeletal Sciences, University of Oxford Professor Ernest Choy, Head Of Rheumatology And Translational Research, Institute Of Infection And Immunity. Director Of Arthritis Research UK CREATE Centre And Welsh Arthritis Research Network (WARN). Cardiff University School Of Medicine, Cardiff
|
|
18.00 – 19.00
Hosted by
Symposia Session
|
iQ Communicator (Part 1) Join us for clinical updates and UK-centric discussions with an expert panel. Designed for UK healthcare professionals specialising in rheumatology, the iQ Communicator series brings the highlights of major international conferences to a UK audience, at a convenient place and before the ‘Hot Topics’ start to cool.
This iQ Communicator event offers an exciting opportunity to revisit the highlights of EULAR 2016 with UK-relevant insights and interpretation from a panel of leading UK experts, helping attendees to keep up to date with the latest research and best practice from across the globe.
In the first part of this iQ Communicator event (Part 2 is on Friday morning) the panel will explore a variety of clinical headaches in rheumatology, and the impact of patient factors on the course of RA and its treatment.
Chair: Professor Peter Taylor, Norman Collison Professor of Musculoskeletal Sciences. Kennedy Institute of Rheumatology, Oxford
Dr Patrick Kiely, Consultant Rheumatologist. St George’s Hospital NHS Trust, London
Dr Elena Nikiphorou, Consultant Rheumatologist. The Whittington Hospital NHS Trust, London
iQ Communicator is a symposium jointly convened by the BSR and Pfizer. The faculty were identified by the BSR and programme Chair, and speakers have selected their own content for the meeting. Logistics support and editorial review in line with the ABPI Code of Practice have been co-ordinated by Pfizer. The symposium is funded by Pfizer as part of its
sponsorship of the BSR Autumn Conference 2016.
|
|
08.00 – 09.00
Hosted by
Symposia Session
|
iQ Communicator (Part 2) This iQ Communicator event offers an exciting opportunity to revisit the highlights of EULAR 2016, and the 10th International Congress on Spondyloarthritides, with UK-relevant insights and interpretation from a panel of leading UK experts, helping attendees to keep up to date with the latest research and best practice from across the globe.
In the second part of this iQ Communicator event (Part 1 is on Thursday evening) the panel will explore advances in our understanding and management of the axial spondyloarthritides, and the latest data relating to the management of RA. Chair: Professor Peter Taylor, Norman Collison Professor of Musculoskeletal Sciences. Kennedy Institute of Rheumatology, Oxford
Dr Raj Sengupta, Consultant Rheumatologist. The Royal National Hospital for Rheumatic Diseases, Bath
Dr Patrick Kiely, Consultant Rheumatologist. St George’s Hospital NHS Trust, London
Dr Elena Nikiphorou, Consultant Rheumatologist. The Whittington Hospital NHS Trust, London
iQ Communicator is a symposium jointly convened by the BSR and Pfizer. The faculty were identified by the BSR and programme Chair, and speakers have selected their own content for the meeting. Logistics support and editorial review in line with the ABPI Code of Practice have been co-ordinated by Pfizer. The symposium is funded by Pfizer as part of its sponsorship of the BSR Autumn Conference 2016.
· · |
|
12.20 – 12.50
Hosted by Innovation Session
|
New Perspectives in Psoriasis: The diagnosis and treatment of subclinical enthesitis We welcome you to discuss early Psoriatic
Arthritis damage, and poor detection levels in Dermatology clinics, including
presentation of the MUSTEK ultrasound data. Prof Dennis Mcgonagle, Professor Of Investigative
Dermatology. University Of Leeds, Leeds Dr Laura Savage, Specialist Registrar In Dermatology. University Of Leeds, Leeds |
